The Icelandic founder mutation BRCA2 999del5: analysis of expression

The Icelandic founder mutation BRCA2 999del5: analysis of expression

Bibliographic Details
Main Authors:	Mikaelsdottir, Evgenia K, Valgeirsdottir, Sigridur, Eyfjord, Jorunn E, Rafnar, Thorunn
Format:	Online
Language:	English
Published:	BioMed Central 2004
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC468616/

Similar Items

BRCA2 interacting proteins
by: Vidarsson, H, et al.
Published: (2000)

Genomic and phenotypic analysis of BRCA2 mutated breast cancers reveals co-occurring changes linked to progression
by: Stefansson, Olafur A, et al.
Published: (2011)

Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers
by: Aradottir, Margret, et al.
Published: (2014)

BRCA1 founder mutations and ovarian cancer in Belarus
by: Savanevich, A, et al.
Published: (2015)

Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer
by: Birgisdottir, Valgerdur, et al.
Published: (2006)

Mahu 999 tahun
by: Wahab, Abdullah
Published: (2012)

Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers
by: Jonasson, Jon G, et al.
Published: (2016)

BRCA Genetic Screening in Middle Eastern and North African: Mutational Spectrum and Founder BRCA1 Mutation (c.798_799delTT) in North African
by: Laraqui, Abdelilah, et al.
Published: (2015)

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population
by: J. Maksimenko, et al.
Published: (2018-06-01)

Characterization of an Italian Founder Mutation in the RING-Finger Domain of BRCA1
by: Caleca, Laura, et al.
Published: (2014)

A Founder Mutation of the BRCA1-Gene in Western Sweden
by: Einbeigi, Zakaria, et al.
Published: (1999)

BRCA1 founder mutations compared to ovarian cancer in Belarus
by: Savanevich, Alena, et al.
Published: (2014)

BRCA2 mutation carriers, reproductive factors and breast cancer risk
by: Tryggvadottir, Laufey, et al.
Published: (2003)

BRCA1 and BRCA2 Mutations Other Than the Founder Alleles Among Ashkenazi Jewish in the Population of Argentina
by: Angela R. Solano, et al.
Published: (2018-08-01)

MR999-E wireless robotic arm
by: Muhammed, Mastura, et al.

Mutation Analysis of the BRCA1 and BRCA2 Genes in the Belgian Patient Population and Identification of a Belgian Founder Mutation BRCA1 IVS5+3A>G
by: Claes, Kathleen, et al.
Published: (1999)

Bit-related lesions in Icelandic competition horses
by: Björnsdóttir, Sigríður, et al.
Published: (2014)

Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families
by: Oros, Kathleen K, et al.
Published: (2006)

BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study.
by: Artur Kowalik, et al.

A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population
by: Belanger, Moria H, et al.
Published: (2015)

Summer eczema in exported Icelandic horses: influence of environmental and genetic factors
by: Björnsdóttir, Sigríður, et al.
Published: (2006)

Studies on electrochemically synthesized polyaniline and its copolymers [QD1-999].
by: Parsa, Ali
Published: (2009)

Proton Saga RM26,999 sempena 50 tahun merdeka
Published: (2008)

Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome
by: Ewald, Ingrid P, et al.
Published: (2011)

Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
by: Hamel, Nancy, et al.
Published: (2003)

Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control
by: Janavičius, Ramūnas
Published: (2010)

Identification of novel BRCA founder mutations in Middle Eastern breast cancer patients using capture and Sanger sequencing analysis
by: Bu, Rong, et al.
Published: (2016)

BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population
by: Ławniczak, Małgorzata, et al.
Published: (2016)

Serological markers of Bornavirus infection found in horses in Iceland
by: Björnsdóttir, Sigríður, et al.
Published: (2013)

Iceland
Published: (1997)

BRCA2 Heterozygosity Delays Cytokinesis in Primary Human Fibroblasts
by: Jonsdottir, Asta Björk, et al.
Published: (2009)

The refractive state of the eye in Icelandic horses with the Silver mutation
by: Maria K. Johansson, et al.
Published: (2017-06-01)

Radiographic closure time of appendicular growth plates in the Icelandic horse
by: Strand, Eric, et al.
Published: (2007)

Recurrent and founder mutations in the Netherlands: the cardiac phenotype of DES founder mutations p.S13F and p.N342D
by: van Spaendonck-Zwarts, K. Y., et al.
Published: (2012)

TP53 mutations in ovarian carcinomas from sporadic cases and carriers of two distinct BRCA1 founder mutations; relation to age at diagnosis and survival
by: Kringen, Pedro, et al.
Published: (2005)

Analysis of Founder Mutations in Rare Tumors Associated With Hereditary Breast/Ovarian Cancer Reveals a Novel Association of BRCA2 Mutations with Ampulla of Vater Carcinomas
by: Pinto, Pedro, et al.
Published: (2016)

Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer.
by: Lehrer, S., et al.
Published: (1998)

Recurrent and founder mutations in the Netherlands—Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy
by: van der Zwaag, P. A., et al.
Published: (2013)

Assessing the Impact of Policy Changes in the Icelandic Cod Fishery Using a Hybrid Simulation Model
by: Sigurðardóttir, Sigríður, et al.
Published: (2014)

Mutation screening of BRCA1, BRCA2 and CHEK2*1100delC in Slovak HBOC families
by: Cierniková, S, et al.
Published: (2005)